ReviewCNS & neurological disorders drug targets2011

Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.

S Michael Owens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.